• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $S

    SentinelOne Inc.

    Subscribe to $S
    $S
    Computer Software: Prepackaged Software
    Technology

    SentinelOne, Inc. operates as a cybersecurity provider in the United States. Its Singularity Platform delivers artificial intelligence-powered autonomous threat prevention, detection, and response capabilities across an organization's endpoints, and cloud workloads, enabling seamless and automatic protection against a spectrum of cyber threats. The company was formerly known as Sentinel Labs, Inc. and changed its name to SentinelOne, Inc. in March 2021. SentinelOne, Inc. was incorporated in 2013 and is headquartered in Mountain View, California.

    IPO Year: 2021

    Exchange: NYSE

    Website: sentinelone.com

    Peers

    $CHKP
    $CRWD
    $FEYE
    $RPD
    $PANW
    $MNDT

    Recent Analyst Ratings for SentinelOne Inc.

    DatePrice TargetRatingAnalyst
    5/29/2025$22.00 → $19.00Overweight → Neutral
    Analyst
    5/29/2025$18.00Overweight → Equal Weight
    Wells Fargo
    5/29/2025$21.00Buy → Neutral
    BofA Securities
    4/23/2025$26.00Buy
    Roth Capital
    4/1/2025$25.00Overweight
    Stephens
    3/18/2025Equal-Weight
    Morgan Stanley
    1/15/2025$32.00Outperform
    Oppenheimer
    1/15/2025$30.00 → $25.00Buy → Neutral
    UBS
    12/19/2024$27.00 → $30.00Hold → Buy
    Jefferies
    12/2/2024Overweight → Equal-Weight
    Morgan Stanley
    See more ratings